PBS updates

Valcyte (Valganciclovir)

valganciclovir 50 mg/mL powder for oral liquid, 100 mL · ORAL · PBS code 9675F

STREAMLINED

What it costs

AU$395.1 PBS-determined price per 11 units

Most patients pay only the standard PBS co-payment, not the full price above — up to AU$25.00 per script (general) or AU$7.70 (concession/Safety Net) in 2026. The figure above is what the PBS pays the pharmacy; the Australian Government subsidises the rest. Always confirm the current amount with your pharmacist.

  • • First listed on the PBS: 2010-08-01.
  • • Repeats: 5.
  • • PBS program: HS.
Eligibility criteria for subsidised access

The following is the government's own wording from the PBS Schedule, shown unchanged.

Listing of Pharmaceutical Benefits (NHL) - Schedule 4 part 1

Cytomegalovirus infection and disease


Patient must be a bone marrow transplant recipient at risk of cytomegalovirus disease.

Listing of Pharmaceutical Benefits (NHL) - Schedule 4 part 1

Cytomegalovirus infection and disease


Patient must be a solid organ transplant recipient at risk of cytomegalovirus disease.

Sponsor: Pharmaco (Australia) Limited ABN 89 113 383 501

Not medical advice. Voxsanity republishes public PBS data in plain English. PBS listing status and criteria can change; always confirm current subsidised availability with your doctor or pharmacist.

Source: Pharmaceutical Benefits Scheme (PBS), © Commonwealth of Australia. Data used and redistributed under permission; not modified from its original wording where displayed verbatim.